Leadership Overview
IntegriChain has 4 executives leading key functions including commercial strategy, technology architecture, operational efficiency, and revenue growth.
Focused on optimizing pharmaceutical market access, IntegriChain delivers advanced data analytics and business process platforms to enhance profitability for global biopharmaceutical manufacturers across the entire product lifecycle.
Focused on optimizing pharmaceutical market access, IntegriChain delivers advanced data analytics and business process platforms to enhance profitability for global biopharmaceutical manufacturers across the entire product lifecycle.
Leadership Roles at IntegriChain
Sean Downey - Chief Operating Officer
Sean Downey, the Chief Operating Officer at IntegriChain, directs internal business processes and service delivery frameworks. Overseeing the execution of market access services, the Chief Operating Officer ensures that operational workflows align with the needs of pharmaceutical manufacturers. This leadership role involves driving efficiency across all departments to support the management of $1 trillion in gross revenue. By optimizing resource allocation and project management methodologies, Sean Downey enhances the delivery of commercialization solutions. The Chief Operating Officer monitors performance metrics to ensure consistent service quality across all client engagements. Through strategic coordination with other C-suite leaders, the Chief Operating Officer maintains organizational agility in a rapidly changing healthcare environment. Ultimately, the Chief Operating Officer drives the operational scale required to support the company's mission of providing comprehensive data and analytics platforms to the biopharmaceutical industry.
Brad Burget - Chief Technology Officer
Brad Burget, the Chief Technology Officer at IntegriChain, architects the scalable data infrastructure powering the ICyte platform. Overseeing software development and engineering teams, the Chief Technology Officer ensures the seamless integration of commercial, financial, and operational data streams. This leadership role involves driving innovation in analytics capabilities to support complex biopharmaceutical lifecycle management. By prioritizing robust security and data integrity, Brad Burget maintains the trust of major biopharma brands managing over $1 trillion in gross revenue. The Chief Technology Officer directs the evolution of technical solutions, ensuring that platform performance meets the high-demand requirements of global pharmaceutical operations. Through continuous refinement of cloud-based architectures, the Chief Technology Officer enables rapid decision-making for clients. Ultimately, the Chief Technology Officer secures the technological foundation necessary for the company to deliver superior market access insights and maintain industry-leading software performance.
Chris Hare - Chief Revenue Officer
Chris Hare, the Chief Revenue Officer at IntegriChain, directs global sales initiatives and market expansion efforts. Overseeing the acquisition of new biopharmaceutical clients, the Chief Revenue Officer ensures that the company's commercialization and market access services reach key industry players. This leadership role involves driving revenue growth by demonstrating the value of the ICyte platform to top-tier brands. By aligning sales strategies with the specific needs of pharmaceutical manufacturers, Chris Hare secures long-term partnerships that support portfolio expansion. The Chief Revenue Officer manages the sales pipeline and monitors market penetration across diverse geographic regions. Through close collaboration with the product and marketing teams, the Chief Revenue Officer refines value propositions to address evolving industry challenges. Ultimately, the Chief Revenue Officer drives the financial success of the organization by expanding the footprint of data-driven solutions within the global biopharmaceutical market.

Walter Worsham - Managing Director
Walter Worsham, the Managing Director at IntegriChain, directs high-level commercialization strategies for pharmaceutical manufacturers. Overseeing complex market access initiatives, the Managing Director ensures alignment between client product portfolios and evolving healthcare regulatory landscapes. This leadership role involves driving long-term value through the integration of financial and operational data within the ICyte platform. By architecting strategic partnerships, Walter Worsham secures competitive advantages for biopharma brands navigating North American markets. The Managing Director maintains rigorous oversight of business process improvements, ensuring that all commercial activities support sustainable revenue growth. Through constant evaluation of market trends, the Managing Director optimizes service delivery models to meet the specific needs of top-tier biopharmaceutical clients. Ultimately, the Managing Director fosters an environment of operational excellence, positioning the organization as a critical partner in the pharmaceutical commercialization ecosystem.
Explore Leadership Teams in Healthcare Software
CorroHealth is a healthcare software company founded in 2006 that specializes in revenue cycle management solutions for the healthcare industry. The company provides comprehensive reimbursement cycle services through its technology-enabled platforms, including emergency documentation systems, advanced coding solutions, and clinical documentation improvement offerings. With a global presence across North America, Europe, Asia, and the Middle East, CorroHealth delivers integrated healthcare technology solutions designed to optimize financial operations for healthcare providers.
Company Leadership TO
RB

JW
Veradigm is a healthcare technology company that provides data-driven solutions and insights for healthcare providers, payers, and life sciences. Their offerings include electronic health records, practice management systems, patient engagement platforms, and advanced analytics for risk adjustment and quality management. Veradigm aims to streamline operations, improve patient care, and enhance financial performance through a comprehensive network of solutions and partnerships. The company is committed to empowering clients with trusted data and insights to reduce costs and improve health outcomes.
Company Leadership
SS
CY
QGenda is a healthcare technology company that provides a specialized workforce management platform designed to help hospitals, health systems, and medical organizations efficiently deploy and manage physicians, nurses, and staff, offering integrated solutions that bring together scheduling, credentialing, time and attendance, on-call coordination, and workforce analytics within a single unified system; the platform emphasizes data-driven decision-making, automation, and AI-powered capabilities to streamline administrative processes, optimize staffing, improve operational efficiency, and enhance patient care delivery, while maintaining a strong focus on addressing the unique complexities of healthcare environments through a purpose-built, industry-specific approach.
Company Leadership

JW
SR
Founded in 2013, Healthmap Solutions is a team of clinical and data analytics employees focused on specialty health management of complex progressive diseases. The company is headquartered in Tampa, Florida.
Company Leadership

NM